Indegene Intrinsic Value
Indegene intrinsic value. Indegene (INDGN) median intrinsic value is ₹1120.00 from 10 valuation models (range ₹194–₹1614), vs current price ₹645.40 — +73.5% upside (Trading Below Calculated Value), margin of safety 42.4%. Browse INDGN balance sheet details for revenue, profit, balance sheet and cash flow data.
INDGN Valuation Methods Summary — DCF, Graham Number & P/E
Indegene intrinsic value across 10 models vs current price ₹645.40 — upside/downside and value range per method. For current market price and key ratios, visit Indegene share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹410.96 | ₹328.77 - ₹493.15 | -36.3% | EPS: ₹18.68, Sector P/E: 22x |
| Book Value Method | asset | ₹1307.92 | ₹1177.13 - ₹1438.71 | +102.7% | Book Value/Share: ₹653.96, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1290.80 | ₹1161.72 - ₹1419.88 | +100.0% | Revenue/Share: ₹947.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1290.80 | ₹1161.72 - ₹1419.88 | +100.0% | EBITDA: ₹804.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1613.50 | ₹1290.80 - ₹1936.20 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹193.62 | ₹174.26 - ₹212.98 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹288.61 | ₹259.75 - ₹317.47 | -55.3% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1120.00 | ₹1008.00 - ₹1232.00 | +73.5% | ROE: 14.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹524.27 | ₹471.84 - ₹576.70 | -18.8% | EPS: ₹18.68, BVPS: ₹653.96 |
| Dividend Yield Method | dividend | ₹193.62 | ₹174.26 - ₹212.98 | -70.0% | DPS: ₹2.25, Target Yield: 2.5% |
INDGN Intrinsic Value vs Market Price — All Valuation Models
Indegene fair value range ₹194–₹1614 vs current market price ₹645.40 across 10 valuation models. Analyse INDGN shareholder distribution to track promoter, FII and institutional holdings.
INDGN Intrinsic Value Analysis — Undervalued or Overvalued?
Indegene median intrinsic value ₹1120.00, current price ₹645.40 — Trading Below Calculated Value by 73.5%, margin of safety 42.4%.
What is the intrinsic value of INDGN?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Indegene (INDGN) is ₹1120.00 (median value). With the current market price of ₹645.40, this represents a +73.5% variance from our estimated fair value.
The valuation range spans from ₹193.62 to ₹1613.50, indicating ₹193.62 - ₹1613.50.
Is INDGN undervalued or overvalued?
Based on our multi-method analysis, Indegene (INDGN) appears to be trading below calculated value by approximately 73.5%.
INDGN Financial Health — Key Ratios vs Industry Benchmarks
Indegene financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 14.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.98x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INDGN Cash Flow Quality — Operating & Free Cash Flow
Indegene operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹651 Cr | ₹397 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹442 Cr | ₹104 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹508 Cr | ₹345 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹130 Cr | ₹-318 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹297 Cr | ₹218 Cr | Positive Free Cash Flow | 8/10 |